Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Daniel Prohaska

Orthopaedic Surgery Wichita, KS Medical Doctor

NPI 1356318570 CMS profile 60963

9828 E Shannon Woods Cir # 100, Wichita, KS 67226

Open in the dashboard

General payments

$4,664

54 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$5,641,826

8 holdings reported · through program year 2025

Through program year 2025, Daniel Prohaska of Wichita, KS is reported in the CMS Open Payments database as having received $4,664 across 54 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $5,641,826 across 8 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 55th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $253 7
2024 General $750 12
2023 General $95 5
2022 General $398 5
2021 General $302 8
2020 General $2,576 8
2019 General $290 9
2025 Ownership $1,287,415 1
2024 Ownership $1,287,415 1
2023 Ownership $1,006,089 1
2022 Ownership $906,089 1
2021 Ownership $624,811 1
2020 Ownership $265,003 1
2019 Ownership $265,003 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Prohaska
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Daniel Prohaska were reported at $253. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Daniel Prohaska Orthopaedic Surgery median Middle half National median
2019 $290 $644 $140–$2,844 $163
2020 $2,576 $312 $75–$1,860 $114
2021 $302 $520 $117–$2,495 $132
2022 $398 $598 $128–$2,731 $149
2023 $95 $461 $128–$2,264 $160
2024 $750 $497 $134–$2,475 $164
2025 $253 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Lima USA, Inc. $2,482 7 payments
  2. Stryker Corporation $1,132 14 payments
  3. Medacta USA, Inc. $254 4 payments
  4. Zimmer Biomet Holdings, Inc. $179 2 payments
  5. Anika Therapeutics, Inc. $139 1 payment
  6. Linvatec Corporation $129 5 payments
  7. Ferring Pharmaceuticals Inc. $77 5 payments
  8. Titan Surgical Group, LLC $38 2 payments
  9. Siemens Medical Solutions USA, Inc. $33 2 payments
  10. DePuy Synthes Sales Inc. $30 2 payments
  11. Other $171 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,464 53 payments
  2. Consulting Fee $2,200 1 payment
Products named General payments · program years 2019–2025
  1. SMR $2,482 7 payments
  2. 1688 HD 3 CHIP CAMERA $206 2 payments
  3. AEQUALIS ASCEND FLEX $165 2 payments
  4. AEQUALIS FLEX REVIVE $163 1 payment
  5. TORNIER PERFORM REVERSED AUGMENTED GLENOID $160 1 payment
  6. Tactoset $139 1 payment
  7. PRIMARY SHOULDER $127 2 payments
  8. Reverse Shoulder $111 1 payment
  9. RIBFIX BLU ADVANTAGE $109 1 payment
  10. 1688 $105 1 payment
  11. Other $902 34 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

66

Median for Orthopedic Surgery: 203

Drug cost

$308

Median for Orthopedic Surgery: $1,433

Branded share of claims

25.8%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 17 $191
Meloxicam Generic 49 $118

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$200,338

Of which drugs: $2,314

Medicare patients

442

Average age 73

Services billed

2,096

227 women, 215 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 72%
Ischemic heart disease 27%
Diabetes 26%
Depression 25%
Chronic kidney disease 18%
Atrial fibrillation 14%
COPD 12%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 124 433 $2,252

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

54 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record